← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2017Last known activity
Oct 31, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (12 distinct, 10 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT07167342CollaboratorPhase 4Oct 31, 2025
- NCT07152886CollaboratorPhase 4Oct 31, 2025
- NCT06902740CollaboratorPhase 4Sep 1, 2025
- NCT07153744CollaboratorPhase 4Sep 1, 2025
- NCT05965193CollaboratorPhase 3Aug 17, 2023
- NCT05965687CollaboratorPhase 3Aug 17, 2023
- NCT05794425CollaboratorPhase 1/Phase 2Aug 1, 2023
- NCT05901779CollaboratorN/AApr 1, 2023
- NCT03175731CollaboratorPhase 4Jun 30, 2017
- NCT02838992CollaboratorPhase 4Feb 1, 2017
Details
- Last known activity
- Oct 31, 2025